v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Class A Common Stock
Preferred Stock
Series A Preferred Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Retained earnings
Accumulated other comprehensive (loss) income
Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2024       0            
Beginning balance at Dec. 31, 2024 $ 1,003,496     $ 0 $ 365,607     $ 715,767 $ (82,344) $ 4,466
Beginning balance (in shares) at Dec. 31, 2024           45,359,425 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 9,668             9,717   (49)
Other comprehensive (loss) income 14,646               14,646  
Issuance of restricted stock (in shares)           143,784        
Tax withholding related to vesting of restricted stock and other (3,178)       (3,178)          
Employee stock purchase program (in shares)           23,015        
Employee stock purchase program 659       659          
Stock option exercises (in shares)           63,409        
Stock option exercises 758       758          
Restricted stock compensation expense 6,667       6,667          
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 98             98    
Cash dividends - common (1,367)             (1,367)    
Ending balance (in shares) at Mar. 31, 2025       0            
Ending balance at Mar. 31, 2025 1,031,447     $ 0 370,513     724,215 (67,698) 4,417
Ending balance (in shares) at Mar. 31, 2025           45,589,633 0      
Beginning balance (in shares) at Dec. 31, 2025   100,000   100,000            
Beginning balance at Dec. 31, 2025 1,254,106     $ 96,266 388,389     809,885 (44,672) 4,238
Beginning balance (in shares) at Dec. 31, 2025     46,032,402     46,032,402 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 29,947             30,040   (93)
Other comprehensive (loss) income (2,680)               (2,680)  
Issuance of restricted stock (in shares)           154,541        
Tax withholding related to vesting of restricted stock and other (3,994)       (3,994)          
Employee stock purchase program (in shares)           17,665        
Employee stock purchase program 484       484          
Stock option exercises (in shares)           36,083        
Stock option exercises 499       499          
Restricted stock compensation expense 6,880       6,880          
Cash dividends - preferred (2,094)             (2,094)    
Cash dividends - common (1,387)             (1,387)    
Ending balance (in shares) at Mar. 31, 2026   100,000   100,000            
Ending balance at Mar. 31, 2026 $ 1,281,761     $ 96,266 $ 392,258     $ 836,444 $ (47,352) $ 4,145
Ending balance (in shares) at Mar. 31, 2026     46,240,691     46,240,691 0